For nephropathy screening associated to disorders such diabetic nephropathy, hypertension, cardiovascular diseases, and chronic kidney disease, the measurement of urinary albumin is considered as a cost-effective procedure which could minimize disease progression [49]. This evidence concerns the gene ALB and hypertensive disorder.